Bank Of America Corp Adma Biologics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 890,662 shares of ADMA stock, worth $17.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

890,662

Previous 539,421 65.11%

Holding current value

$17.4 Million

Previous $3.56 Million 179.69%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $2.1 Million - $3.93 Million	351,241 Added 65.11%	890,662 $9.96 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $3.77 Million - $5.77 Million	-856,122 Reduced 61.35%	539,421 $3.56 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $242,697 - $356,166	-78,798 Reduced 5.34%	1,395,543 $6.31 Million
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $1.18 Million - $1.6 Million	-379,033 Reduced 20.45%	1,474,341 $5.44 Million
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $1.91 Million - $2.46 Million	635,688 Added 52.2%	1,853,374 $6.13 Million
Q4 2022 Feb 10, 2023	BUY	$2.47 - $3.88 $638,206 - $1 Million	258,383 Added 26.93%	1,217,686 $4.72 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $650,345 - $916,249	320,367 Added 50.14%	959,303 $2.33 Million
Q2 2022 Aug 12, 2022	SELL	$1.43 - $2.2 $511,909 - $787,553	-357,979 Reduced 35.91%	638,936 $1.27 Million
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $465,377 - $665,344	363,576 Added 57.41%	996,915 $1.82 Million
Q4 2021 Feb 08, 2022	BUY	$1.09 - $1.66 $160,151 - $243,900	146,928 Added 30.21%	633,339 $894,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $4,985 - $7,279	-4,412 Reduced 0.9%	486,411 $549,000
Q2 2021 Sep 13, 2021	BUY	$1.51 - $2.07 $741,142 - $1.02 Million	490,823 New	490,823 $786,000

Others Institutions Holding ADMA

# of Institutions

265

Shares Held

178M

Call Options Held

535K

Put Options Held

21.2K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.84B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Adma Biologics, Inc. Transaction History